---
title: "BioLineRx Reports 2025 Financial Results and Provides Corporate Update | BLRX Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280147189.md"
description: "BioLineRx Reports 2025 Financial Results and Provides Corporate Update | BLRX Stock News"
datetime: "2026-03-23T03:00:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280147189.md)
  - [en](https://longbridge.com/en/news/280147189.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280147189.md)
---

# BioLineRx Reports 2025 Financial Results and Provides Corporate Update | BLRX Stock News

BioLineRx Reports 2025 Financial Results and Provides Corporate Update | BLRX Stock News

### Related Stocks

- [BLRX.US](https://longbridge.com/en/quote/BLRX.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)

## Related News & Research

- [TuHURA Biosciences Reports First Quarter 2026 Financial Results and Provides a Corporate Update | HURA Stock News](https://longbridge.com/en/news/286615229.md)
- [NeurAxis Reports Record First Quarter 2026 Financial Results Driven by 80% Year Over Year Revenue Growth | NRXS Stock News](https://longbridge.com/en/news/286085829.md)
- [Acrivon Therapeutics, Inc. (ACRV) Receives a Buy from Oppenheimer](https://longbridge.com/en/news/286428001.md)
- [Eton Pharmaceuticals Q1 product sales rise driven by portfolio expansion](https://longbridge.com/en/news/286461579.md)
- [Analyst Reiterates Buy on Corbus, Maintains $38 Price Target on CRB-701 Oncology Potential](https://longbridge.com/en/news/286284525.md)